Multidirectional Management for HCC With Innovative Immunotherapy and Targeted Platforms

Chair, Ghassan Abou-Alfa, MD, MBA, Lipika Goyal, MD, Ahmed Omar Kaseb, MD, CMQ, Amit Singal, MD, MS,and discuss HCC in this CME/MOC/AAPA activity titled “Renovating the Clinical Rulebook for HCC: Multidirectional Management With Innovative Immunotherapy and Targeted Platforms.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UUY865. CME/MOC/AAPA credit will be available until July 2, 2024.

свернуть